![](https://pbs.twimg.com/media/EW3wBGzWsAAe1fl.jpg)
![](https://pbs.twimg.com/media/EW3wJX8XsAIKo9F.png)
Fortunately, we already have a head start on the first phase of vaccine development: research. nyti.ms/3d3AhR4
![](https://pbs.twimg.com/media/EW3wyK8XsAQvLCt.png)
![](https://pbs.twimg.com/media/EW3xK-zXkAI_IlE.png)
“The manufacturing task is insurmountable,” said Vijay Samant, the former head of vaccine manufacturing at Merck. “I get sleepless nights thinking about it.” nyti.ms/3d3AhR4
![](https://pbs.twimg.com/media/EW3xWTWXsAIgrtx.png)
Read on. nyti.ms/3d3AhR4